Prediction of survival after neoadjuvant chemotherapy for breast cancer by evaluation of tumor-infiltrating lymphocytes (TILs) and residual cancer burden (RCB)

被引：0
|
作者：
Asano, Y.
Kashiwagi, S.
Goto, W.
Takada, K.
Takashima, T.
Morisaki, T.
Noda, S.
Onoda, N.
Ohsawa, M.
Hirakawa, K.
Ohira, M.
机构：
[1] Osaka City Univ, Grad Sch Med, Osaka, Japan
[2] Osaka City Univ, Grad Sch Med, Deaprtment Diagnost Pathol, Osaka, Japan
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.SABCS16-P2-05-05
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-05-05
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Prediction of survival after neoadjuvant chemotherapy for breast cancer by evaluation of tumor-infiltrating lymphocytes and residual cancer burden
    Asano, Yuka
    Kashiwagi, Shinichiro
    Goto, Wataru
    Takada, Koji
    Takahashi, Katsuyuki
    Hatano, Takaharu
    Noda, Satoru
    Takashima, Tsutomu
    Onoda, Naoyoshi
    Tomita, Shuhei
    Motomura, Hisashi
    Ohsawa, Masahiko
    Hirakawa, Kosei
    Ohira, Masaichi
    BMC CANCER, 2017, 17
  • [2] Prediction of survival after neoadjuvant chemotherapy for breast cancer by evaluation of tumor-infiltrating lymphocytes and residual cancer burden
    Yuka Asano
    Shinichiro Kashiwagi
    Wataru Goto
    Koji Takada
    Katsuyuki Takahashi
    Takaharu Hatano
    Satoru Noda
    Tsutomu Takashima
    Naoyoshi Onoda
    Shuhei Tomita
    Hisashi Motomura
    Masahiko Ohsawa
    Kosei Hirakawa
    Masaichi Ohira
    BMC Cancer, 17
  • [3] Prediction of survival after neoadjuvant chemotherapy for breast cancer by evaluation of tumor-infiltrating lymphocytes within fibrotic foci of tumor stroma (FF-TILs)
    Kashiwagi, S.
    Asano, Y.
    Goto, W.
    Takada, K.
    Takashima, T.
    Morisaki, T.
    Noda, S.
    Onoda, N.
    Hirakawa, K.
    Ohira, M.
    ANNALS OF ONCOLOGY, 2017, 28 : 18 - 18
  • [4] Correlation of Tumor-Infiltrating Lymphocytes (TILs) with Residual Cancer Burden in Patients Treated with Neoadjuvant Chemotherapy (NAC) for Invasive Breast Carcinoma with a Focus on TILs Assessment in Heterogeneous Cases
    Cheng, Esther
    Demaria, Sandra
    Ko, David
    Chen, Zhengming
    Moo, Tracy-Ann
    Andreopoulou, Eleni
    D'Alfonso, Timothy
    MODERN PATHOLOGY, 2017, 30 : 34A - 34A
  • [5] Correlation of Tumor-Infiltrating Lymphocytes (TILs) with Residual Cancer Burden in Patients Treated with Neoadjuvant Chemotherapy (NAC) for Invasive Breast Carcinoma with a Focus on TILs Assessment in Heterogeneous Cases
    Cheng, Esther
    Demaria, Sandra
    Ko, David
    Chen, Zhengming
    Moo, Tracy-Ann
    Andreopoulou, Eleni
    D'Alfonso, Timothy
    LABORATORY INVESTIGATION, 2017, 97 : 34A - 34A
  • [6] A composite prognostic model for overall survival (OS) based on residual cancer burden (RCB) and tumor-infiltrating lymphocytes (TILs) on residual disease (RCB plus TIL) in HER2+breast cancer patients treated with neoadjuvant therapy: a multicenter study
    Miglietta, F.
    Ragazzi, M.
    Fernandes, B.
    Griguolo, G.
    Massa, D.
    Bisagni, A.
    Bottosso, M.
    Porra, F.
    Gaudio, M.
    Iannaccone, D.
    Fassan, M.
    Lo Mele, M.
    Gasparini, E.
    Zarrilli, G.
    Coiro, S.
    Dore, L.
    Zambelli, A.
    Bisagni, G.
    Guarneri, V.
    Dieci, M. V.
    EUROPEAN JOURNAL OF CANCER, 2022, 175 : S3 - S3
  • [7] Significance of tumor-infiltrating lymphocytes in breast cancer with neoadjuvant chemotherapy
    Miyoshi, Y.
    Shien, T.
    Omori, M.
    Abe, Y.
    Watanabe, A.
    Hara, A.
    Mizoo, T.
    Nogami, T.
    Taira, N.
    Doihara, H.
    BREAST, 2015, 24 : S124 - S124
  • [8] Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple-negative breast cancer patients after neoadjuvant chemotherapy
    Luen, S. J.
    Salgado, R.
    Dieci, M. V.
    Vingiani, A.
    Curigliano, G.
    Gould, R. E.
    Castaneda, C.
    D'Alfonso, T.
    Sanchez, J.
    Cheng, E.
    Andreopoulou, E.
    Castillo, M.
    Adams, S.
    Demaria, S.
    Symmans, W. F.
    Michiels, S.
    Loi, S.
    ANNALS OF ONCOLOGY, 2019, 30 (02) : 236 - 242
  • [9] Prediction of the treatment response to eribulin chemotherapy in breast cancer using tumor-infiltrating lymphocytes (TILs)
    Shinichiro, Kashiwagi
    Asano, Yuka
    Goto, Wataru
    Kurata, Kento
    Morisaki, Tamami
    Noda, Satoru
    Takashima, Tsutomu
    Onoda, Naoyoshi
    Tanaka, Sayaka
    Ohsawa, Masahiko
    Ohira, Masaichi
    Hirakawa, Kosei
    CANCER RESEARCH, 2016, 76
  • [10] Development of tumor-infiltrating lymphocytes in breast cancer after neoadjuvant paclitaxel chemotherapy
    Demaria, S
    Volm, MD
    Shapiro, RL
    Yee, HT
    Oratz, R
    Formenti, SC
    Muggia, F
    Symmans, WF
    CLINICAL CANCER RESEARCH, 2001, 7 (10) : 3025 - 3030
12345